Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance) In a Danish national population-based study of 3,055 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results